SEC Filings

Form S-3
ZOMEDICA PHARMACEUTICALS CORP. filed this Form S-3 on 12/26/2018
Document Outline
Entire Document (350.3 KB)
Subdocument 1 - S-3 - FORM S-3
Page 1 - As filed with the Securities and Exchange Commission on December 21, 2018
Page 2 - Approximate date of commencement of proposed sale to the public: From time to time after this Regist
Page 3 - The registrant hereby amends this registration statement on such date or dates as may be necessary t
Page 4 - The information in this prospectus is not complete and may be changed. The selling shareholders name
Page 5 - TABLE OF CONTENTS
Page 6 - ABOUT THIS PROSPECTUS
Page 7 - PROSPECTUS SUMMARY
Page 8 - N/A
Page 9 - Implications of Being an Emerging Growth Company
Page 10 - The Offering
Page 11 - SELLING SHAREHOLDERS
Page 12 - N/A
Page 13 - N/A
Page 14 - Relationships with Selling Shareholders
Page 15 - DESCRIPTION OF SECURITIES
Page 16 - Rights upon Liquidation
Page 17 - Action Necessary to Change the Rights of Holders of our Shares
Page 18 - Certain Take-over Bid Requirements
Page 19 - MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS
Page 20 - N/A
Page 21 - The following summary is not a substitute for careful tax planning and advice. U.S. Holders of commo
Page 22 - N/A
Page 23 - N/A
Page 24 - General Rules Applicable to the Ownership and Disposition of Common Shares
Page 25 - Additional Considerations
Page 26 - N/A
Page 27 - N/A
Page 28 - CERTAIN CANADIAN INCOME TAX CONSIDERATIONS
Page 29 - N/A
Page 30 - PLAN OF DISTRIBUTION
Page 31 - N/A
Page 32 - LEGAL MATTERS
Page 33 - N/A
Page 34 - Up to 80,863,744 Common Shares
Page 35 - PART II
Page 36 - Item 16. Exhibits.
Page 37 - N/A
Page 38 - N/A
Page 39 - SIGNATURES
Page 40 - EXHIBIT INDEX
Subdocument 2 - EX-5.1 - EXHIBIT 5.1
Page 1 - N/A
Subdocument 3 - EX-23.1 - EXHIBIT 23.1
Page 1 - N/A